Supplement GMP Compliance Means Staying On Top Of Reasons For Consumer Doubt
This article was originally published in The Tan Sheet
Consumers have a new reason to doubt supplement safety “every single day,” says Lisa Thomas, general manager of NSF’s Certified for Sport program. More NSF clients are correcting GMP problems after an initial audit, “a really good thing because nobody likes to tell you to do something and then have to tell you again, especially the FDA,” she says.
You may also be interested in...
CDER Office of New Drugs changes its organization including establishing Office of Nonprescription Drugs and splitting the office into Division of Nonprescription Drug Products I and DNDP II. A Division of Regulatory Operations for Nonprescription Drugs will be comprised of regulatory staff from the ONPD divisions and will report to OND’s regulatory office. Non-clinical ONPD staff will report to the office director.
FDA has little in the way of good information it can list on its CBD policy agenda so far, says Principal Deputy Commissioner Amy Abernethy. At recent regulatory conference, she said, "Like it or not, there is a massive human experiment going on right now. There’s CBD in most different product categories and people of many different backgrounds with potential vulnerabilities taking CBD."